The 'Fred Factor': The Saga of a Turnaround Specialist

ICMR HOME | Case Studies Collection

Case Details:

Case Code : LDEN066
Case Length : 17 Pages
Period : 1995-2009
Pub Date : 2010
Teaching Note : Available
Organization : -
Industry : Pharmaceuticals
Countries : US; Global

To download The 'Fred Factor': The Saga of a Turnaround Specialist case study (Case Code: LDEN066) click on the button below, and select the case from the list of available cases:

Price:

For delivery in electronic format: Rs. 300;
For delivery through courier (within India): Rs. 300 + Shipping & Handling Charges extra

» Leadership and Entrepreneurship Case Studies
» Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company

Custom Search

Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.

Chat with us

Please leave your feedback

<< Previous

The Turnaround King of the Pharmaceutical Industry Contd...

According to analysts, Hassan widely known as the turnaround expert in the pharmaceutical industry played a major role in orchestrating the deal.

Calling the deal with Merck the right transaction at the right time, Hassan said, "Over the last six years, Schering-Plough colleagues have transformed our company into a strong competitor in the global pharmaceutical industry. We have built a strong, diverse business and a robust pipeline that offers hope to patients who are waiting for new medicines. I am proud of what we have accomplished. Our success is a testament to the hard work and dedication of our colleagues in every country.

Leadership and Entrepreneurship Case Studies | Case Study in Management, Operations, Strategies, Leadership and Entrepreneurship, Case Studies

We are joining forces with Merck, our long-term partner in our cholesterol joint venture, to create a dynamic new leader in the pharmaceutical industry. By harnessing the strengths of both companies, the combined entity will be well-positioned to further deliver on our shared goal of discovering new therapies for patients to help them live healthier, happier lives."⁵...

Excerpts >>

5] "Merck and Schering-Plough to Merge," www.schering-plough.com, March 9, 2009.

Custom Search


Leadership and Change Management Textbook Textbooks Collection	Scams and Scandals Case Volume Work Book - Rs. 750 Case Study Volumes Collection	Leadership in Practice Case Volume Case Study Volumes Collection